TechMARK movers: C&W Worldwide bid rumours

6th Sep 2010 13:58

There are rumours that Cable & Wireless Worldwide could be the subject of a bid from Singapore Telecoms. It appears that any potential bid is at an early stage. The rise in the share price could stop C&W Worldwide being demoted from the FTSE 100 index. GlaxoSmithKline is lower after the British Medical Journal said that its diabetes drug Avandia should be withdrawn from sale. According to the BMJ, in July the Commission on Human Medicines advised the Medicines and Healthcare products Regulatory Agency to withdraw Avandia from sale because its risks outweigh its benefits. Avandia, also known as rosiglitazone, is thought to lead to heart problems. Sales have the drug have already slumped because of negative studies in the US. Second quarter revenues were £152m. GlaxoSmithKline rejects the claims. FTSE TechMARK - RisersParity Group (PTY) 7.25p +6.90%Torotrak (TRK) 21.50p +4.65%Imagination Technologies (IMG) 381.50p +3.72%CSR (CSR) 307.60p +3.08%Spectris (SXS) 970.00p +2.97%Cable & Wireless Worldwide (CW.) 75.10p +2.95%Vectura Group (VEC) 52.75p +2.43%Asterand (ATD) 10.75p +2.38%NXT (NTX) 11.00p +2.27%Network Technology (NTY) 2,200.00p +2.27%FTSE TechMARK - FallersVislink (VLK) 16.75p -5.63%Emblaze (BLZ) 50.25p -5.63%Phytopharm (PYM) 9.38p -4.05%ProStrakan (PSK) 77.00p -2.53%BATM Advanced (BVC) 24.25p -2.02%Sinclair Pharma (SPH) 26.75p -1.87%Consort Medical (CSRT) 415.25p -1.60%GlaxoSmithKline (GSK) 1,250.50p -1.42%Electronic Data Processing (EDP) 45.00p -1.11%Renovo Group (RNVO) 22.50p -1.10%